5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo

5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...

5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...

5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare

5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

5/21/2025CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy

5/21/2025CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...

5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102

5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC

5/20/2025ArkBio Announces Positive Phase II Results of AK3280

5/20/2025SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration

5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial

5/20/2025WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal

5/20/2025JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...

5/20/2025Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...

Page:9/53 Total number of articles:1578: [First][<<] [7] [8] [9] [10] [11] [>>] [End]